Rajkumar Vincent

Professor, Hematology ,Mayo Clinic 

Location: United States

Consulting Services


Areas Of Interest

Survival Multiple Myeloma Monoclonal Gammopathy of Undetermined Significance Immunoglobulin Light-chain Amyloidosis Lenalidomide Smoldering Multiple Myeloma Dexamethasone Plasma Cells

Professional Narrative

S. Vincent Rajkumar, M.D., is engaged in clinical, epidemiological and laboratory research in myeloma and related disorders. Dr. Rajkumar served as the principal investigator on several clinical trials for the treatment of myeloma, including the pivotal trials that led to the regulatory approval of thalidomide for the treatment of the disease in the United States.

Focus areas

  • Biomarkers for diagnosis of multiple myeloma and related disorders
  • Novel therapies for multiple myeloma
  • Epidemiology and prognosis of myeloma and related monoclonal gammopathies
  • Clinical trials for myeloma and related disorders
  • Racial disparities in myeloma and related plasma cell disorders

Significance to patient care

The research being conducted by Dr. Rajkumar will lead to better treatments and outcomes for patients with myeloma and other hematologic malignancies.


Employment


Education


Referees


Publications


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :